2001-2005, Master in natural product chemistry, Fudan University
2005-2011, Ph.D. and postdoctoral research in organic chemistry, Emory University, USA
Engaged in the computer-aided design, total synthesis and pharmacological research of natural products with anticancer activity.
2011-2014, Senior Scientist, Eli Lilly & Company, Indinapolis Corporate Center and Lilly China Research and Development Center in Shanghai,
Engaged in the discovery of first- in-class small molecule anti-diabetic drugs which led to a Phase I clinical trial in China.
Master of pharmacology, China Pharmaceutical University (CPU)
Worked in the research institute of Shanghai Pharmaceutical Group, Engaged in the pharmacological research and clinical registration of new agents.
